 |
The Journal of Neuroscience, July 30, 2003, 23(17):6703-6712
Previous Article | Next Article 
Impaired NMDA Receptor-Mediated Postsynaptic Function and Blunted NMDA Receptor-Dependent Persistent Pain in Mice Lacking Postsynaptic Density-93 Protein
Yuan-Xiang Tao,1 *
Gavin Rumbaugh,2 *
Guo-Du Wang,3 *
Ronald S. Petralia,4
Chengshui Zhao,1
Frederick W. Kauer,5
Feng Tao,1
Min Zhuo,3
Robert J. Wenthold,4
Srinivasa N. Raja,1
Richard L. Huganir,2
David S. Bredt,5 and
Roger A. Johns1
1Department of Anesthesiology and Critical Care
Medicine and 2Howard Hughes Medical Institute,
Department of Neuroscience, Johns Hopkins University School of Medicine,
Baltimore, Maryland 21287, 3Washington University Pain
Center, Departments of Anesthesiology, Anatomy and Neurobiology, and
Psychiatry, Washington University School of Medicine, St. Louis, Missouri
63110, 4Laboratory of Neurochemistry, National
Institute on Deafness and Other Communication Disorders, National Institutes
of Health, Bethesda, Maryland 20892, and 5Department
of Physiology, University of California San Francisco, San Francisco,
California 94143-0444
Modification of synaptic NMDA receptor (NMDAR) expression influences
NMDAR-mediated synaptic function and associated persistent pain. NMDARs
directly bind to a family of membrane-associated guanylate kinases (MAGUKs)
that regulate surface and synaptic NMDAR trafficking in the CNS. We report
here that postsynaptic density-93 protein (PSD-93), a postsynaptic neuronal
MAGUK, is expressed abundantly in spinal dorsal horn and forebrain, where it
colocalizes and interacts with NMDAR subunits NR2A and NR2B. Targeted
disruption of the PSD-93 gene reduces not only surface NR2A and NR2B
expression but also NMDAR-mediated excitatory postsynaptic currents and
potentials, without affecting surface AMPA receptor expression or its synaptic
function, in the regions mentioned above. Furthermore, mice lacking PSD-93
exhibit blunted NMDAR-dependent persistent pain induced by peripheral nerve
injury or injection of Complete Freund's Adjuvant, although they display
intact nociceptive responsiveness to acute pain. PSD-93 appears to be
important for NMDAR synaptic targeting and function and to be a potential
biochemical target for the treatment of persistent pain.
Key words: PSD-93; NMDA receptors; surface expression; persistent pain; spinal cord, forebrain
Received Mar. 4, 2003;
revised Jun. 4, 2003;
accepted Jun. 10, 2003.
This article has been cited by other articles:

|
 |

|
 |
 
J.-S. Park, N. Voitenko, R. S. Petralia, X. Guan, J.-T. Xu, J. P. Steinberg, K. Takamiya, A. Sotnik, O. Kopach, R. L. Huganir, et al.
Persistent Inflammation Induces GluR2 Internalization via NMDA Receptor-Triggered PKC Activation in Dorsal Horn Neurons
J. Neurosci.,
March 11, 2009;
29(10):
3206 - 3219.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Conway, N. White, C. St. Jean, W. T. Zempsky, and K. Steven
Use of Continuous Intravenous Ketamine for End-Stage Cancer Pain in Children
Journal of Pediatric Oncology Nursing,
March 1, 2009;
26(2):
100 - 106.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
C. M. McDermott, M. N. Hardy, N. G. Bazan, and J. C. Magee
Sleep deprivation-induced alterations in excitatory synaptic transmission in the CA1 region of the rat hippocampus
J. Physiol.,
February 1, 2006;
570(3):
553 - 565.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Ravasi, H. Suzuki, K. C. Pang, S. Katayama, M. Furuno, R. Okunishi, S. Fukuda, K. Ru, M. C. Frith, M. M. Gongora, et al.
Experimental validation of the regulated expression of large numbers of non-coding RNAs from the mouse genome
Genome Res.,
January 1, 2006;
16(1):
11 - 19.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L.-J. Wu, H. Toyoda, M.-G. Zhao, Y.-S. Lee, J. Tang, S. W. Ko, Y. H. Jia, F. W. F. Shum, C. V. Zerbinatti, G. Bu, et al.
Upregulation of Forebrain NMDA NR2B Receptors Contributes to Behavioral Sensitization after Inflammation
J. Neurosci.,
November 30, 2005;
25(48):
11107 - 11116.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. I. Nam and L. Chen
Postsynaptic assembly induced by neurexin-neuroligin interaction and neurotransmitter
PNAS,
April 26, 2005;
102(17):
6137 - 6142.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Lin, V. A. Skeberdis, A. Francesconi, M. V. L. Bennett, and R. S. Zukin
Postsynaptic Density Protein-95 Regulates NMDA Channel Gating and Surface Expression
J. Neurosci.,
November 10, 2004;
24(45):
10138 - 10148.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. J. Chung, Y. H. Huang, L.-F. Lau, and R. L. Huganir
Regulation of the NMDA Receptor Complex and Trafficking by Activity-Dependent Phosphorylation of the NR2B Subunit PDZ Ligand
J. Neurosci.,
November 10, 2004;
24(45):
10248 - 10259.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. L. Leyland and C. Dart
An Alternatively Spliced Isoform of PSD-93/Chapsyn 110 Binds to the Inwardly Rectifying Potassium Channel, Kir2.1
J. Biol. Chem.,
October 15, 2004;
279(42):
43427 - 43436.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R.-R. Ji and G. Strichartz
Cell Signaling and the Genesis of Neuropathic Pain
Sci. Signal.,
September 28, 2004;
2004(252):
re14 - re14.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y.-X. Tao and R. A. Johns
NEURONAL PDZ DOMAINS: A Promising New Molecular Target for Inhaled Anesthetics?
Mol. Interv.,
August 1, 2004;
4(4):
215 - 221.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|